A detailed history of Gamma Investing LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Gamma Investing LLC holds 14,491 shares of LLY stock, worth $11.3 Million. This represents 1.27% of its overall portfolio holdings.

Number of Shares
14,491
Previous 11,658 24.3%
Holding current value
$11.3 Million
Previous $10.6 Billion 21.63%
% of portfolio
1.27%
Previous 1.44%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$772.14 - $960.02 $2.19 Million - $2.72 Million
2,833 Added 24.3%
14,491 $12.8 Billion
Q2 2024

Jul 02, 2024

BUY
$724.87 - $909.04 $3.52 Million - $4.41 Million
4,853 Added 71.32%
11,658 $10.6 Billion
Q1 2024

Apr 05, 2024

BUY
$592.2 - $792.28 $568,512 - $760,588
960 Added 16.42%
6,805 $5.29 Billion
Q4 2023

Feb 01, 2024

BUY
$525.19 - $619.13 $3.07 Million - $3.62 Million
5,845 New
5,845 $3.77 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.